Science ❯ Psychology

Psychedelics

Therapeutic Effects Psilocybin Clinical Trials Research Therapeutic Use Therapeutic Applications Drug Development Research Methods Research Studies Effects on Mind DMT Ibogaine Effects LSD Substance Use Disorders Neuroscience Research Methodology Drug Research

3 ARTICLES

last mo.

FDA Holds Public Hearing as White House Pushes Faster Path for Psychedelic Therapies

The agency collected practical input on training, screening, clinic capacity, safety tracking, access and reimbursement to help shape potential accelerated approval paths.

5 ARTICLES

2mo ago

Oregon Study Finds State‑Regulated Psilocybin Services Linked to Large Mental‑Health Gains

5 ARTICLES

2mo ago

Psilocybin Therapy Puts Most Veterans With Treatment‑Resistant PTSD Into Remission

7 ARTICLES

4mo ago

Definium’s Oral LSD Pill Meets Primary Endpoint in Phase 3 Depression Trial

4 ARTICLES

5mo ago

Compass Pathways Rises on Q1 Beat as FDA Accepts Rolling Review for COMP360

9 ARTICLES

5mo ago

Single High Dose of Psilocybin Tied to Lasting Brain Changes and Month-Later Well-Being

7 ARTICLES

6mo ago

Trump Order to Speed Psychedelic Therapies Sends Compass Pathways to 52-Week High

4 ARTICLES

7mo ago

New Analysis Finds Psychedelic Therapy Matches Antidepressants for Major Depression

5 ARTICLES

8mo ago

Compass Pathways’ Psilocybin Therapy Hits Phase 3 Goal in Treatment-Resistant Depression

5 ARTICLES

8mo ago

Single IV Dose of DMT Shows Rapid, Lasting Antidepressant Effects in Small Trial

4 ARTICLES

this yr.

Single Psilocybin Dose Plus Mindfulness Eases Depression for Frontline Clinicians in Randomized Trial

3 ARTICLES

last yr.

Single Psilocybin Dose Offers Long-Term Relief for Cancer-Related Depression

6 ARTICLES

last yr.

Single Psilocybin Dose Delivers Two-Year Relief From Depression and Anxiety in Cancer Patients

3 ARTICLES

last yr.

Global Experts Release ReSPCT Guidelines to Standardize Psychedelic Trial Reporting